XML 39 R128.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Selected Quarterly Financial Data (Unaudited) - Selected Quarterly Financial Data (Detail) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Selected Quarterly Financial Information [Line Items]                      
Net revenues $ 4,468 $ 4,093 $ 4,177 $ 4,149 $ 4,419 $ 4,385 $ 4,552 $ 4,916 $ 16,887 $ 18,271 $ 21,853
Gross profit 1,958 1,830 1,893 1,856 1,971 1,977 2,033 2,315 7,537 8,296 10,615
Net income (loss) 75 (307) (671) (97) (3,243) (197) (166) 1,134 (1,000) (2,472) (16,449)
Net income (loss) attributable to Teva 110 (314) (689) (105) (2,886) (208) (176) 1,120 (999) (2,150) (16,265)
Net income (loss) attributable to ordinary shareholders $ 110 $ (314) $ (689) $ (105) $ (2,940) $ (273) $ (241) $ 1,055 $ (999) $ (2,399) $ (16,525)
Earnings per share attributable to ordinary shareholders:                      
Basic $ 0.10 $ (0.29) $ (0.63) $ (0.10) $ (2.85) $ (0.27) $ (0.24) $ 1.04 $ (0.91) $ (2.35) $ (16.26)
Diluted $ 0.10 $ (0.29) $ (0.63) $ (0.10) $ (2.85) $ (0.27) $ (0.24) $ 1.03 $ (0.91) $ (2.35) $ (16.26)